Charles River Laboratories International Inc. Stock Advances 11.4%, Outperforms Peers
Dow Jones2026/08/05 20:32This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. climbed 11.4% to $260.72 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.5% to 54,349.12 and the S&P 500 Index falling 0.2% to 7,723.55.
This was the stock's second consecutive day of gains.
Charles River Laboratories International Inc. hit a new 52-week high, surpassing its previous peak of $242.73, which the company reached on July 28th.
The stock outperformed some of its peers, as Labcorp Holdings Inc. rose 0.5% to $313.96, Alnylam Pharmaceuticals Inc. rose 4.4% to $228.72, and Bio-Techne Corp. fell 0.12% to $72.00.
Trading volume totaled 1.8 million, compared to the 50-day average of 865,690.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 05, 2026 16:32 ET (20:32 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The 10-year U.S. Treasury yield climbs to 4.8%, erasing the dividend advantage of utility stocks; the sector’s rebound depends on interest rate stabilization rather than technical signals.
As U.S. Treasury yields continue to climb, the American utilities sector is experiencing a significant pullback—a rise in yields not only erodes the relative appeal of the sector’s dividends but also raises financing costs for the most capital-intensive industries within this market.
Euro holds gains above 1.1600 despite robust US jobs data, traders eye ECB rate decision
Port of Tauranga wins fast-track approval for Stella Passage development
Crypto prices
More
